Our Heritage
Adcock Ingram was first listed on the Johannesburg Stock Exchange (JSE) in 1950 and enjoyed blue chip status. In 2000 Tiger Brands (then the majority shareholder) acquired the minority shares, and Adcock Ingram was delisted from the JSE and operated as a wholly owned subsidiary of Tiger Brands. On 25 August 2008, Adcock Ingram was unbundled from Tiger Brands and relisted on the JSE
Take a journey with us and explore our rich history to see how we've continually evolved to keep up with the expectations and needs of all our stakeholders.
-
1890
EJ Adcock Pharmacy Krugersdorp
-
1937
Camphor Cream Launched
-
1940
Pharmaceutical manufacturing facility
-
1948
Licence agreement Baxter Healthcare
-
1950
Listed on the Johannesburg Stock Exchange (JSE)
-
1987
Myprodol Analgesic Launched
-
1996
Merger between Adcock Ingram and Premier Pharmaceuticals
-
1999
Construction of the R & D Centre
-
2005
Launch of Generic ARV's
-
2007
Joint Venture with Medreich Limited
Formation of Adcock Bangalore
-
2008
State-of-the-art Distribution Centre Midrand
Extend Baxter Contract
Unbundled from Tiger Brands
Relisted on JSE
-
2010
Acquired 66.2% of Ayrton Drug Manufacturing
Launch Durban Distribution Facility
-
2013
Reorganisation of the Group into 4 autonomous BU’s
-
2018
Acquistion of Genop Healthcare
-
2019
Bidvest increases shareolding to majority stake
-
2020
Acquisition of Plush Homecare
-
2021
OTC Division wins exclusive distribution rights to Mundipharma Betadine and Teejel products New Ophthalmic facility approved by SAHPRA